Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
M Ashrafizadeh, CD Mohan… - Medicinal research …, 2023 - Wiley Online Library
Gastrointestinal (GI) tumors (cancers of the esophagus, gastric, liver, pancreas, colon, and
rectum) contribute to a large number of deaths worldwide. STAT3 is an oncogenic …
rectum) contribute to a large number of deaths worldwide. STAT3 is an oncogenic …
Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities
Although cancer is still one of the most significant global challenges facing public health, the
world still lacks complementary approaches that would significantly enhance the efficacy of …
world still lacks complementary approaches that would significantly enhance the efficacy of …
Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer
F Lin, X Li, X Wang, H Sun, Z Wang, X Wang - Journal of Experimental & …, 2022 - Springer
Abstract Background Stanniocalcin 1 (STC1) plays an integral role in ovarian cancer (OC).
However, the functional role of STC1 in metastasis, lipid metabolism and cisplatin (DDP) …
However, the functional role of STC1 in metastasis, lipid metabolism and cisplatin (DDP) …
Current options and future directions for NAFLD and NASH treatment
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with a broad spectrum ranging from simple steatosis to advanced stage of …
worldwide, with a broad spectrum ranging from simple steatosis to advanced stage of …
Pathology and pathogenesis of metabolic dysfunction-associated steatotic liver disease-associated hepatic tumors
Y Takahashi, E Dungubat, H Kusano, T Fukusato - Biomedicines, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in
the livers of patients without a history of alcohol abuse. It is classified as either simple …
the livers of patients without a history of alcohol abuse. It is classified as either simple …
Diagnosis and therapeutic management of liver fibrosis by MicroRNA
T Tadokoro, A Morishita, T Masaki - International Journal of Molecular …, 2021 - mdpi.com
Remarkable progress has been made in the treatment and control of hepatitis B and C viral
infections. However, fundamental treatments for diseases in which liver fibrosis is a key …
infections. However, fundamental treatments for diseases in which liver fibrosis is a key …
[HTML][HTML] MicroRNAs in the pathogenesis of nonalcoholic fatty liver disease
Z Fang, G Dou, L Wang - International journal of biological …, 2021 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD), or, more accurately, metabolic associated fatty
liver disease, accounts for a large proportion of chronic liver disorders worldwide and is …
liver disease, accounts for a large proportion of chronic liver disorders worldwide and is …
miR‐21‐5p promotes NASH‐related hepatocarcinogenesis
Abstract Background and Aims The mechanisms governing the progression of non‐
alcoholic fatty liver disease (NAFLD) towards steatohepatitis (NASH) and hepatocellular …
alcoholic fatty liver disease (NAFLD) towards steatohepatitis (NASH) and hepatocellular …
[HTML][HTML] Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease
Y Fan, W Dong, Y Wang, S Zhu, R Chai, Z Xu… - Frontiers in …, 2022 - frontiersin.org
Macrophages are involved in hepatocyte steatosis and necroinflammation and play an
important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Impaired …
important role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Impaired …
Zebrafish facilitate non‐alcoholic fatty liver disease research: Tools, models and applications
C Chang, H Li, R Zhang - Liver International, 2023 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) has become an increasingly epidemic metabolic
disease worldwide. NAFLD can gradually deteriorate from simple liver steatosis …
disease worldwide. NAFLD can gradually deteriorate from simple liver steatosis …